Abstract
The coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential.
Author supplied keywords
Cite
CITATION STYLE
Chang, J. Y. C., Woo, C. S. L., Lui, D. T. W., Fung, M. M. H., Lee, A. C. H., Leung, E. K. H., … Lee, C. H. (2022). Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.957369
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.